These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18042431)

  • 21. In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection.
    Asquith B; Zhang Y; Mosley AJ; de Lara CM; Wallace DL; Worth A; Kaftantzi L; Meekings K; Griffin GE; Tanaka Y; Tough DF; Beverley PC; Taylor GP; Macallan DC; Bangham CR
    Proc Natl Acad Sci U S A; 2007 May; 104(19):8035-40. PubMed ID: 17483473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
    Kagdi H; Demontis MA; Ramos JC; Taylor GP
    PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is human T-cell lymphotropic virus type I really silent?
    Asquith B; Hanon E; Taylor GP; Bangham CR
    Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1013-9. PubMed ID: 11186302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of TSLC1 in patients with HAM/TSP.
    Takenouchi N; Tanaka M; Sato T; Yao J; Fujisawa JI; Izumo S; Kubota R; Matsuura E
    J Neurovirol; 2020 Jun; 26(3):404-414. PubMed ID: 32285300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.
    Hanon E; Hall S; Taylor GP; Saito M; Davis R; Tanaka Y; Usuku K; Osame M; Weber JN; Bangham CR
    Blood; 2000 Feb; 95(4):1386-92. PubMed ID: 10666215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1.
    Wodarz D; Hall SE; Usuku K; Osame M; Ogg GS; McMichael AJ; Nowak MA; Bangham CR
    Proc Biol Sci; 2001 Jun; 268(1473):1215-21. PubMed ID: 11410146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
    Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
    Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of HTLV-1 orf-I encoded proteins in viral transmission and persistence.
    Sarkis S; Galli V; Moles R; Yurick D; Khoury G; Purcell DFJ; Franchini G; Pise-Masison CA
    Retrovirology; 2019 Dec; 16(1):43. PubMed ID: 31852543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
    de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
    J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide.
    Nose H; Kubota R; Seth NP; Goon PK; Tanaka Y; Izumo S; Usuku K; Ohara Y; Wucherpfennig KW; Bangham CR; Osame M; Saito M
    J Infect Dis; 2007 Dec; 196(12):1761-72. PubMed ID: 18190256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of chronic progressive myelopathy associated with human T-cell lymphotropic virus type I.
    Höllsberg P
    Acta Neurol Scand Suppl; 1997; 169():86-93. PubMed ID: 9174644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
    Jacobson S; Shida H; McFarlin DE; Fauci AS; Koenig S
    Nature; 1990 Nov; 348(6298):245-8. PubMed ID: 2146511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection.
    Abdelbary NH; Abdullah HM; Matsuzaki T; Hayashi D; Tanaka Y; Takashima H; Izumo S; Kubota R
    J Infect Dis; 2011 Apr; 203(7):948-59. PubMed ID: 21402546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HTLV-I infection: a dynamic struggle between viral persistence and host immunity.
    Lim AG; Maini PK
    J Theor Biol; 2014 Jul; 352():92-108. PubMed ID: 24583256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HTLV-1 infections.
    Bangham CR
    J Clin Pathol; 2000 Aug; 53(8):581-6. PubMed ID: 11002759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of human T-cell leukemia virus type 1 (HTLV-1) proviral loads in rats orally infected with HTLV-1 by reimmunization with HTLV-1-infected cells.
    Komori K; Hasegawa A; Kurihara K; Honda T; Yokozeki H; Masuda T; Kannagi M
    J Virol; 2006 Aug; 80(15):7375-81. PubMed ID: 16840318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection.
    Manns A; Miley WJ; Wilks RJ; Morgan OS; Hanchard B; Wharfe G; Cranston B; Maloney E; Welles SL; Blattner WA; Waters D
    J Infect Dis; 1999 Nov; 180(5):1487-93. PubMed ID: 10515807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
    Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
    J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment.
    Césaire R; Dehée A; Lézin A; Désiré N; Bourdonné O; Dantin F; Béra O; Smadja D; Abel S; Cabié A; Sobesky G; Nicolas JC
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):799-805. PubMed ID: 11429121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.